Notch signaling in postnatal pituitary expansion: Proliferation, progenitors, and cell specification

Molecular Endocrinology

Volumn 28, Issue 5, 2014, Pages 731-744

  Nantie, Leah B ^a   Himes, Ashley D ^a   Getz, Dan R ^a   Raetzman, Lori T ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS HORMONE; NOTCH RECEPTOR; PROTEIN; PROTEIN PROP1; TRANSCRIPTION FACTOR PIT 1; UNCLASSIFIED DRUG; GROWTH HORMONE; NOTCH2 PROTEIN, MOUSE; NOTCH2 RECEPTOR; PIT1 PROTEIN, MOUSE; PROOPIOMELANOCORTIN; THYROTROPIN BETA SUBUNIT;

ACTH SECRETING CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE; GENE EXPRESSION; GENE MUTATION; HYPOPHYSIS; KNOCKOUT MOUSE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NOTCH2 GENE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROP1 GENE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; 129 MOUSE; ANIMAL; CYTOLOGY; EMBRYONIC STEM CELL; GENETICS; METABOLISM; PHYSIOLOGY; TISSUE CULTURE TECHNIQUE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CORTICOTROPHS; EMBRYONIC STEM CELLS; GENE EXPRESSION; GROWTH HORMONE; MICE, 129 STRAIN; MICE, KNOCKOUT; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; RECEPTOR, NOTCH2; SIGNAL TRANSDUCTION; THYROTROPIN, BETA SUBUNIT; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION FACTOR PIT-1;

EID: 84899754016     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2013-1425     Document Type: Article

References (61)

1. Regal M, Paramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001; 55: 735-740.
2. Prince KL, Walvoord EC, Rhodes SJ. The role of homeodomain transcription factors in heritable pituitary disease. Nat Rev Endocrinol. 2011; 7: 727-737.
3. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT. Genetic regulation of pituitary gland development in human and mouse. Endocr Rev. 2009; 30: 790-829.
4. Cogan JD, WuW, Phillips JA, et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab. 1998; 83: 3346-3349.
5. Wu W, Cogan JD, Pfäffle RW, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet. 1998; 18: 147-149.
6. Flück C, Deladoey J, Rutishauser K, et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg3Cys at codon 120 (R120C). J Clin Endocrinol Metab. 1998; 83: 3727-3734.
7. Pernasetti F, Toledo SP, Vasilyev VV, et al. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. J Clin Endocrinol Metab. 2000; 85: 390-397.
8. Agarwal G, Bhatia V, Cook S, Thomas PQ. Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab. 2000; 85: 4556-4561.
9. Böttner A, Keller E, Kratzsch J, et al. PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab. 2004; 89: 5256-5265.
10. Sornson MW, Wu W, Dasen JS, et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature. 1996; 384: 327-333.
11. Nasonkin IO, Ward RD, Raetzman LT, et al. Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet. 2004; 13: 2727-2735.
12. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA. The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol. 1996; 10: 1570-1581.
13. Zhu X, Zhang J, Tollkuhn J, et al. Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis. Genes Dev. 2006; 20: 2739-2753.
14. Raetzman LT, Ross SA, Cook S, Dunwoodie SL, Camper SA, Thomas PQ. Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression. Dev Biol. 2004; 265: 329-340.
15. Mortensen AH, MacDonald JW, Ghosh D, Camper SA. Candidate genes for panhypopituitarism identified by gene expression profiling. Physiol Genomics. 2011; 43: 1105-1116.
16. Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009; 137: 216-233.
17. Monahan P, Rybak S, Raetzman LT. The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary. Endocrinology. 2009; 150: 4386-4394.
18. Raetzman LT, Cai JX, Camper SA. Hes1 is required for pituitary growth and melanotrope specification. Dev Biol. 2007; 304: 455-466.
19. Raetzman LT, Wheeler BS, Ross SA, Thomas PQ, Camper SA. Persistent expression of Notch2 delays gonadotrope differentiation. Mol Endocrinol. 2006; 20: 2898-2908.
20. Goldberg LB, Aujla PK, Raetzman LT. Persistent expression of activated Notch inhibits corticotrope and melanotrope differentiation and results in dysfunction of the HPA axis. Dev Biol. 2011; 358: 23-32.
21. Tando Y, Fujiwara K, Yashiro T, Kikuchi M. Localization of Notch signaling molecules and their effect on cellular proliferation in adult rat pituitary. Cell Tissue Res. 2013; 351: 511-519.
22. Chen J, Crabbe A, Van Duppen V, Vankelecom H. The notch signaling system is present in the postnatal pituitary: marked expression and regulatory activity in the newly discovered side population. Mol Endocrinol. 2006; 20: 3293-3307.
23. Carbajo-Pérez E, Watanabe YG. Cellular proliferation in the anterior pituitary of the rat during the postnatal period. Cell Tissue Res. 1990; 261: 333-338.
24. Taniguchi Y, Yasutaka S, Kominami R, Shinohara H. Mitoses of thyrotrophs contribute to the proliferation of the rat pituitary gland during the early postnatal period. Anat Embryol. 2002; 206: 67-72.
25. Taniguchi Y, Yasutaka S, Kominami R, Shinohara H. Proliferation and differentiation of rat anterior pituitary cells. Anat Embryol. 2002; 206: 1-11.
26. Taniguchi Y, Yasutaka S, Kominami R, Shinohara H. Proliferation and differentiation of pituitary somatotrophs and mammotrophs during late fetal and postnatal periods. Anat Embryol. 2001; 204: 469-475.
27. Taniguchi Y, Kominami R, Yasutaka S, Kawarai Y. Proliferation and differentiation of pituitary corticotrophs during the fetal and postnatal period: a quantitative immunocytochemical study. Anat Embryol. 2000; 201: 229-234.
28. Gaston-Massuet C, Andoniadou CL, Signore M, et al. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci USA. 2011; 108: 11482-11487.
29. Gremeaux L, Fu Q, Chen J, Vankelecom H. Activated phenotype of the pituitary stem/progenitor cell compartment during the earlypostnatal maturation phase of the gland. Stem Cells Dev. 2012; 21: 801-813.
30. Wang Y, Martin JF, Bai CB. Direct and indirect requirements of Shh/Gli signaling in early pituitary development. Dev Biol. 2010; 348: 199-209.
31. McCright B, Lozier J, Gridley T. Generation of new Notch2 mutant alleles. Genesis. 2006; 44: 29-33.
32. Hébert JM, McConnell SK. Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures. Dev Biol. 2000; 222: 296-306.
33. Himes AD, Raetzman LT. Premature differentiation and aberrant movement of pituitary cells lacking both Hes1 and Prop1. Dev Biol. 2009; 325: 151-161.
34. Cushman LJ, Watkins-Chow DE, Brinkmeier ML, et al. Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility. Hum Mol Genet. 2001; 10: 1141-1153.
35. Zhu X, Gleiberman AS, Rosenfeld MG. Molecular physiology of pituitary development: signaling and transcriptional networks. Physiol Rev. 2007; 87: 933-963.
36. Fauquier T, Rizzoti K, Dattani M, Lovell-Badge R, Robinson IC. SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci USA. 2008; 105: 2907-2912.
37. Garcia-Lavandeira M, Quereda V, Flores I, et al. A GRFa2/Prop1/stem (GPS) cell niche in the pituitary. PLoS One. 2009; 4: e4815.
38. Bilodeau S, Roussel-Gervais A, Drouin J. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells. Mol Cell Biol. 2009; 29: 1895-1908.
39. Dovey HF, John V, Anderson JP, et al. Functional γ-secretase inhibitors reduce β-amyloid peptide levels in brain. J Neurochem. 2001; 76: 173-181.
40. Sastre M, Steiner H, Fuchs K, et al. Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2001; 2: 835-841.
41. Geling A, Steiner H, Willem M, Bally-Cuif L, Haass C. A γ-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 2002; 3: 688-694.
42. Weng AP, Millholland JM, Yashiro-Ohtani Y, et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 2006; 20: 2096-2109.
43. Wang H, Zou J, Zhao B, et al. Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proc Natl Acad Sci USA. 2011; 108: 14908-14913.
44. Chadwick N, Zeef L, Portillo V, et al. A Identification of novel Notch target genes in T cell leukaemia. Mol Cancer. 2009; 8: 35.
45. Murtaugh LC, Stanger BZ, Kwan KM, Melton DA. Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci USA. 2003; 100: 14920-14925.
46. Ohtsuka T, Sakamoto M, Guillemot F, Kageyama R. Roles of the basic helix-loop-helix genes Hes1 and Hes5 in expansion of neural stem cells of the developing brain. J Biol Chem. 2001; 276: 30467-30474.
47. Siveke JT, Lubeseder-Martellato C, Lee M, et al. Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology. 2008; 134: 544-555.
48. Patten BA, Peyrin JM, Weinmaster G, Corfas G. Sequential signaling through Notch1 and erbB receptors mediates radial glia differentiation. J Neurosci. 2003; 23: 6132-6140.
49. Budry L, Balsalobre A, Gauthier Y, et al. The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling. Genes Dev. 2012; 26: 2299-2310.
50. Rizzoti K, Akiyama H, Lovell-Badge R. Mobilized adult pituitary stem cells contribute to endocrine regeneration in response to physiological demand. Cell Stem Cell. 2013; 13: 419-432.
51. Andoniadou CL, Matsushima D, Mousavy Gharavy SN, et al. Sox2+ stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell. 2013; 13: 433-445.
52. Jayakody SA, Andoniadou CL, Gaston-Massuet C, et al. SOX2 regulates the hypothalamic-pituitary axis at multiple levels. J Clin Invest. 2012; 122: 3635-3646.
53. Li Y, Hibbs MA, Gard AL, Shylo NA, Yun K. Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1. Stem Cells. 2012; 30: 741-752.
54. Moran TB, Goldberg LB, Serviss SL, Raetzman LT. Numb deletion in POMC-expressing cells impairs pituitary intermediate lobe cell adhesion, progenitor cell localization, and neuro-intermediate lobe boundary formation. Mol Endocrinol. 2011; 25: 117-127.
55. Rizzoti K. Adult pituitary progenitors/stem cells: from in vitro characterization to in vivo function. Eur J Neurosci. 2010; 32: 2053-2062.
56. Kita A, Imayoshi I, Hojo M, et al. Hes1 and Hes5 control the progenitor pool, intermediate lobe specification, and posterior lobe formation in the pituitary development. Mol Endocrinol. 2007; 21: 1458-1466.
57. Kashiwabara Y, Sasaki S, Matsushita A, et al. Functions of PIT1 in GATA2-dependent transactivation of the thyrotropin β promoter. J Mol Endocrinol. 2009; 42: 225-237.
58. Suga H, Kadoshima T, Minaguchi M, et al. Self-formation of functional adenohypophysis in three-dimensional culture. Nature. 2011; 480: 57-62.
59. Ward RD, Raetzman LT, Suh H, Stone BM, Nasonkin IO, Camper SA. Role of PROP1 in pituitary gland growth. Mol Endocrinol. 2005; 19: 698-710.
60. Gage PJ, Roller ML, Saunders TL, Scarlett LM, Camper SA. Anterior pituitary cells defective in the cell-autonomous factor, df, undergo cell lineage specification but not expansion. Development. 1996; 122: 151-160.
61. Castinetti F, Reynaud R, Saveanu A, Barlier A, Brue T. Genetic causes of combined pituitary hormone deficiencies in humans. Ann Endocrinol (Paris). 2012; 73: 53-55.